Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000214925

Medchemexpress LLC (5S,6R)-Methyl 5,6,7-trihydroxyheptanoate | 78606-80-1 | MFCD00211214 | >98.0% | 192.21 g/mol | C8H16O5 | 1 ML
SDP

Catalog No. 5000214925
Encompass_Preferred

BML-111 is a lipoxin A4 analog and a potent lipoxin A4 receptor (FPR2/ALX) agonist used in research to modulate inflammation, angiogenesis, and immune responses. It is supplied in research-grade formats with high purity and is suitable for in vitro pharmacology and cell signaling studies.

  • High purity suitable for research use.
  • Available as a 10 mM solution in DMSO and as solid forms.
  • Molecular weight 192.21 g/mol; molecular formula C8H16O5.
  • Used to study lipoxin signaling, inflammation, and tumor models.
  • Provided in small laboratory quantities for easy handling and dosing.

Catalog No. 50-002-14925 Supplier Medchemexpress LLC Supplier No. HY10045010MM 1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

BML-111 is a lipoxin A4 analog and a potent lipoxin A4 receptor (FPR2/ALX) agonist used in research to modulate inflammation, angiogenesis, and immune responses. It is supplied in research-grade formats with high purity and is suitable for in vitro pharmacology and cell signaling studies.

  • High purity suitable for research use.
  • Available as a 10 mM solution in DMSO and as solid forms.
  • Molecular weight 192.21 g/mol; molecular formula C8H16O5.
  • Used to study lipoxin signaling, inflammation, and tumor models.
  • Provided in small laboratory quantities for easy handling and dosing.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.